768 related articles for article (PubMed ID: 16970019)
1. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.
Heidelbaugh JJ; Bruderly M
Am Fam Physician; 2006 Sep; 74(5):756-62. PubMed ID: 16970019
[TBL] [Abstract][Full Text] [Related]
2. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
Garcia-Tsao G; Lim JK;
Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
[TBL] [Abstract][Full Text] [Related]
3. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
4. Independent prognostic factors in patients with liver cirrhosis.
Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
[TBL] [Abstract][Full Text] [Related]
5. Steatosis and portal hypertension.
Puoti C; Bellis L
Eur Rev Med Pharmacol Sci; 2005; 9(5):285-90. PubMed ID: 16231591
[TBL] [Abstract][Full Text] [Related]
6. [Fatal acute hepatic failure with hepatocarcinoma presentation in a patient with renal transplant with asymptomatic chronic B and C hepatitis].
Ridruejo E; Avagnina A; Davalos Michel M; Mandó OG
Medicina (B Aires); 2001; 61(5 Pt 1):585-8. PubMed ID: 11721327
[TBL] [Abstract][Full Text] [Related]
7. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
Bedossa P
Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
[TBL] [Abstract][Full Text] [Related]
8. Cirrhosis: diagnosis, management, and prevention.
Starr SP; Raines D
Am Fam Physician; 2011 Dec; 84(12):1353-9. PubMed ID: 22230269
[TBL] [Abstract][Full Text] [Related]
9. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
[TBL] [Abstract][Full Text] [Related]
12. [Reevaluation of the typing criteria for patients with chronic severe hepatitis].
Zeng Z; Han YK; Geng H; Chen JM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):53-5. PubMed ID: 16816864
[TBL] [Abstract][Full Text] [Related]
13. NASH and HCC.
Page JM; Harrison SA
Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of cirrhosis in adults].
Beaugrand M
Rev Prat; 1997 Mar; 47(5):487-90. PubMed ID: 9138409
[TBL] [Abstract][Full Text] [Related]
15. [Etiology and clinical aspects of liver cirrhosis].
Horak W
Z Gesamte Inn Med; 1977 Jan; 32(1):16-22. PubMed ID: 855388
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology and natural history of cirrhosis].
Naveau S; Perlemuter G; Balian A
Rev Prat; 2005 Sep; 55(14):1527-32. PubMed ID: 16255293
[TBL] [Abstract][Full Text] [Related]
17. [Cirrhosis].
Hillaire S; Voitot H
Pathol Biol (Paris); 1999 Nov; 47(9):895-902. PubMed ID: 10609269
[TBL] [Abstract][Full Text] [Related]
18. The global impact of hepatic fibrosis and end-stage liver disease.
Lim YS; Kim WR
Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
[TBL] [Abstract][Full Text] [Related]
20. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
Khandwalla HE; Fasakin Y; El-Serag HB
Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
